NCT00867217 - Vitamin D3 for Aromatase Inhibitor Induced Arthralgias | Biotech Hunter

Enrollment

160

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions

Breast Cancer

Interventions

DIETARY_SUPPLEMENT

High Dose Vitamin D

High Dose Vitamin D3 (3 capsules of 10,000 IU) weekly for 24 weeks.

DIETARY_SUPPLEMENT

Placebo

Placebo comparator

DIETARY_SUPPLEMENT

Standard Dose Vitamin D3

Standard Dose Vitamin D3 (600 IU of vitamin D3 daily)

DRUG

Letrozole 2.5mg

All subjects received letrozole as standard of care.

Trial Locations (2)

University of Kansas Medical Center, Westwood

Cancer Centers of Kansas, P.A., Wichita